Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -35.99-579.49-62.36150.21-353.26

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -35.99 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36
Mar2021150.21
Mar2020-353.26

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36
Negative
Mar2021 150.21
Positive
Mar2020 -353.26 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹210.8 Cr -11.7% -20.9% -32.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,862.0 Cr 1.4% 2.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹174,125.0 Cr 7.1% 8.8% 10.3% Stock Analytics
CIPLA ₹125,454.0 Cr 3.9% -1.3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,106.0 Cr -1.3% -1.3% 2.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,263.0 Cr 0.2% -6% -4.1% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-11.7%

-20.9%

-32.9%

SENSEX

0.1%

0.6%

0.7%


You may also like the below Video Courses